Lindbrook Capital »

Moonlake Immunot shares owned by Lindbrook Capital

Quarter-by-quarter ownership of Moonlake Immunot (MLTX) shares owned by Lindbrook Capital from 13F filings

Historical chart of Lindbrook Capital investment in Moonlake Immunot

Tip: Access up to 7 years of quarterly data

All positions including Moonlake Immunot held by Lindbrook Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Moonlake Immunot by Lindbrook Capital

Quarter filed Position value Share count Share price at filing
2025-03-31 $156 4 39.00

More positions owned by Lindbrook Capital

Vanguard Total Stk Mkt Etf (VTI)
Vanguard Total Intl Stock Idex Etf Etf (VXUS)
Apple Stock (AAPL)
Golub Cap Bdc Cef (GBDC)
Spdr S&p 500 Etf Trust Etf (SPY)
Ishares Russell 1000 Growth Etf Etf (IWF)
Nvidia Corporation Stock (NVDA)
Microsoft Stock (MSFT)
Rpar Risk Parity Etf Etf (RPAR)
Amazon.com Stock (AMZN)
Ishares Russell 1000 Value Etf Etf (IWD)
Powershares Qqq Tr Etf (QQQ)
Broadcom Stock (AVGO)
Berkshire Hathaway Inc Del Cl B Stock (BRK.B)
Google Stock (GOOGL)

View all positions for Lindbrook Capital

Top funds holding Moonlake Immunot

BVF
venBio Select Advisor
Cormorant Asset Management
Balyasny Asset Management
Adage Capital Partners GP
Ikarian Capital
Schonfeld Strategic Advisors
Susquehanna International
Jane Street
Boothbay Fund Management
Caption Management
FMR
Nuveen
Citadel Advisors
Two Sigma Investments

View all funds holding Moonlake Immunot